tiprankstipranks
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
Holding AMRX?
Track your performance easily

Amneal Pharmaceuticals (AMRX) Financial Statements

498 Followers

Amneal Pharmaceuticals Financial Overview

Amneal Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.684; its P/E ratio is -11.36; Amneal Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 702.47M$ 701.78M$ 659.19M$ 616.98M$ 620.04M
Gross Profit$ 269.56M$ 249.95M$ 238.06M$ 189.83M$ 232.53M
EBIT$ 15.46M$ 33.85M$ -73.57M$ 26.63M$ 73.87M
EBITDA$ 75.86M$ 90.35M$ -17.76M$ 84.86M$ 131.07M
Net Income Common Stockholders$ -156.00K$ 5.99M$ -91.64M$ -98.65M$ 9.68M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 74.01M$ 43.77M$ 46.52M$ 91.54M$ 86.93M
Total Assets$ 3.46B$ 3.51B$ 3.46B$ 3.47B$ 3.69B
Total Debt$ 2.53B$ 2.58B$ 2.63B$ 2.75B$ 2.69B
Net Debt$ 2.46B$ 2.54B$ 2.59B$ 2.66B$ 2.60B
Total Liabilities$ 2.65B$ 2.70B$ 2.75B$ 2.72B$ 2.77B
Stockholders Equity$ -93.43M$ -57.47M$ -63.72M$ 19.78M$ 330.86M
Cash Flow-
Free Cash Flow$ 121.23M$ 28.28M$ -23.31M$ 104.13M$ 67.91M
Operating Cash Flow$ 141.77M$ 39.66M$ -4.41M$ 135.82M$ 81.39M
Investing Cash Flow$ -20.71M$ -6.46M$ -19.76M$ -31.69M$ -13.48M
Financing Cash Flow$ -92.35M$ -35.09M$ -23.16M$ -100.83M$ -86.58M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

Amneal Pharmaceuticals Debt to Assets

Amneal Pharmaceuticals Cash Flow

Amneal Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis